With a market capitalization (market cap) of $3.82B — a measure of how much the company is worth — Envista Holdings Corp ranks #1,518 among the 2,418 companies tracked, and 182nd in Healthcare as of November 18, 2026. Shares trade at $23.84, up 0.63% on the day.
As of November 18, 2026 · Prices may be delayed
of 2,418 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series and can differ when the share count changes. Returns below show the total change over each period. Use the CAGR calculator to calculate an annualized return. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation November 13, 2026. The headline market cap is from the ranking update on November 18, 2026.
| Year | As of | Market cap | Annual change | Share-price close |
|---|---|---|---|---|
| 2026Latest available | Nov 13, 2026 | $3.94B | +10.67% | $24.49 |
| 2025 | Dec 31, 2025 | $3.56B | +7.00% | $21.71 |
| 2024 | Dec 31, 2024 | $3.33B | -19.50% | $19.29 |
| 2023 | Dec 29, 2023 | $4.13B | -24.87% | $24.06 |
Ranking figure $3.82B as of November 18, 2026.
Market cap = share price × shares outstanding.
Envista Holdings Corp's ranking market cap is the reported market cap from the latest ranking update, with a share price of $23.81 as of November 18, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $3.94B on November 13, 2026. See how the ranking works.
Current shares outstanding are unavailable from the latest quote. Shares outstanding vs. float.
The latest annual report (FY 2025) used a weighted-average 168,000,000 shares. That figure is an average for the year, not the live count in the market-cap formula.
Book equity: assets minus liabilities on the latest annual report.
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Quote as of . Prices may be delayed. Day figures refer to the quote's trading session.
Latest quote: $23.81. The headline price of $23.84 is from the ranking update on Nov 18, 2026. These updates can differ in timing.
Largest U.S.-listed companies in the same sector. These companies may serve different markets.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #11 | Eli Lilly and Company LLY | $1.31T | -1.68% |
| #19 | Johnson & Johnson JNJ | $664.04B | -1.00% |
| #23 |
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2025.
Visit websiteAs of November 18, 2026, Envista Holdings Corp (NVST) is worth $3.82B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2025, Envista Holdings Corp’s book equity is about $3.11B. Market cap is the market value of the outstanding shares. As of November 18, 2026, its market cap is $3.82B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Envista Holdings Corp ranks #1,518 among the 2,418 companies tracked on MarketCapLens. In Healthcare it ranks #182 of 353.
Financial figures are annual and labeled with their fiscal year (FY). Current-price P/E uses the latest available share price and annual earnings per share.
| 2022 | Dec 30, 2022 | $5.5B | -36.46% | $33.67 |
|---|
| 2021 | Dec 31, 2021 | $8.65B | — | $45.06 |
|---|
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
FY 2025
Return on equity data unavailable for FY 2025
FY 2025
Return on assets data unavailable for FY 2025
FY 2025
| $508.92B |
| -1.58% |
| #31 | Merck & Co., Inc. MRK | $342.3B | -3.09% |
| #35 | UnitedHealth Group Incorporated UNH | $318.26B | -8.69% |
| #38 | Novartis AG NVS | $294.55B | -1.99% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #1515 | Ermenegildo Zegna N.V. ZGN | $3.83B | +3.30% |
| #1516 | Construction Partners, Inc. ROAD | $3.83B | +0.92% |
| #1517 | Bath & Body Works, Inc. BBWI | $3.82B | +3.07% |
| #1519 | Tarsus Pharmaceuticals, Inc. TARS | $3.82B | -1.24% |
| #1520 | First BanCorp. FBP | $3.82B | -0.02% |
| #1521 | Corporacion America Airports S.A. CAAP | $3.81B | -3.03% |
Envista Holdings Corp’s ranking market cap of $3.82B comes from the same snapshot as the rest of this site, as of November 18, 2026. It is not share price multiplied by the FY 2025 weighted-average share count of 168,000,000. The historical market-cap series last observed $3.94B on November 13, 2026.
Over the past year, Envista Holdings Corp’s market cap is up 20.43%, using historical market-cap records rather than today’s share count applied to past prices.
Envista Holdings Corp (NVST) shares trade at $23.84, up 0.63% on the day, as of November 18, 2026.
Envista Holdings Corp trades at a live price-to-earnings (P/E) ratio of 85.0, using the latest share price divided by the latest annual earnings per share. That is not the same as a fiscal-year reported P/E.